by admin_63069 | Jun 8, 2023 | News You Can Use
Read the latest from Urology Times.
by admin_63069 | Jun 5, 2023 | News You Can Use
Two thirds of all cancers are environmentally linked in some way.
by admin_63069 | Jun 1, 2023 | News You Can Use
“These results validate the clinical value of bone biomarker assessment in the hormone-sensitive prostate cancer state,” state the authors.
by admin_63069 | May 29, 2023 | News You Can Use
Researchers examined the impact of deep learning–based AI software upon radiologists reviewing multiparametric MRI scans in the assessment of clinically significant prostate cancer.
by admin_63069 | May 25, 2023 | News You Can Use
A database analysis showed that zoledronic acid led to a 64% reduction in fracture risk among patients with metastatic hormone-sensitive prostate cancer.
by admin_63069 | May 22, 2023 | News You Can Use
Patients with metastatic castration-resistant prostate cancer treated with radioligand therapy, a form of targeted therapy, had improvements in PSA levels and survival with favorable side effect profiles.
